[Mechanisms of drug-induced hepatitis]

Discovery and characterization of selective small molecule inhibitors of the mammalian mitochondrial division dynamin, DRP1.

Biochemical and biophysical research communications·2018

Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.

Alimentary pharmacology & therapeutics·2017

Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.

Journal of viral hepatitis·2016

Liver stiffness diminishes with antiviral response in chronic hepatitis C.

Alimentary pharmacology & therapeutics·2011

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings.

British journal of pharmacology·2011

Endocannabinoids and their role in fatty liver disease.

Digestive diseases (Basel, Switzerland)·2010

[In utero treatment of twin-to-twin transfusion syndrome].

La Revue du praticien·2026

[In utero treatment of spina bifida].

La Revue du praticien·2026

[Syphilis and pregnancy].

La Revue du praticien·2026

[Second-line treatments for Parkinson's disease].

La Revue du praticien·2026

[Ageism in healthcare: sad prejudices!]

La Revue du praticien·2026

[Vaccination for pregnant women].

La Revue du praticien·2026

Indications for the treatment of primary hyperparathyroidism.

Journal of visceral surgery·2026

Sodium valproate at concentrations bracketing estimated seminal plasma levels impairs human sperm function in vitro through oxidative stress and mitochondrial dysfunction.

Toxicology·2026

Pharmacokinetics of repeated, high-dose fentanyl administration in rats.

Drug metabolism and disposition: the biological fate of chemicals·2026

A landscape analysis of Japanese tolerability assessments in oncology drug development.

Cancer treatment and research communications·2026

Opioid and Stimulant Coprescriptions among South Carolina Residents.

Southern medical journal·2026

Opioid Dispensing Volume and Per-Patient Intensity in Sickle Cell Disease.

JAMA network open·2026

Related Experiment Videos

[Mechanisms of drug-induced hepatitis]

Related Concept Videos

Discovery and characterization of selective small molecule inhibitors of the mammalian mitochondrial division dynamin, DRP1.

Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.

Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.

Liver stiffness diminishes with antiviral response in chronic hepatitis C.

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings.

Endocannabinoids and their role in fatty liver disease.

[In utero treatment of twin-to-twin transfusion syndrome].

[In utero treatment of spina bifida].

[Syphilis and pregnancy].

[Second-line treatments for Parkinson's disease].

[Ageism in healthcare: sad prejudices!]

[Vaccination for pregnant women].

Indications for the treatment of primary hyperparathyroidism.

Sodium valproate at concentrations bracketing estimated seminal plasma levels impairs human sperm function in vitro through oxidative stress and mitochondrial dysfunction.

Pharmacokinetics of repeated, high-dose fentanyl administration in rats.

A landscape analysis of Japanese tolerability assessments in oncology drug development.

Opioid and Stimulant Coprescriptions among South Carolina Residents.

Opioid Dispensing Volume and Per-Patient Intensity in Sickle Cell Disease.

Related Experiment Videos

[Mechanisms of drug-induced hepatitis]

Related Concept Videos

Related Articles